Detection bias and overestimation of bladder cancer risk in type 2 diabetes: A matched cohort study

Diabetes Care

Volumn 36, Issue 10, 2013, Pages 3070-3075

  Colmers, Isabelle N ^a   Majumdar, Sumit R ^a   Yasui, Yutaka ^a   Bowker, Samantha L ^a   Marra, Carlo A ^b   Johnson, Jeffrey A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; AMBULATORY CARE; ARTICLE; BLADDER CANCER; CANADA; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX; SOCIAL STATUS;

ADULT; AGED; CANADA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 84891852683     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0045     Document Type: Article

References (21)

1. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007;121: 856-862
2. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97:1679-1687
3. Huxley R, Ansary-MoghaddamA, Berrington de Gonzalez A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-2083
4. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50:1365-1374
5. Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 2012;130:1639-1648
6. Larsson SC, Orsini N, Brismar K,Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia 2006; 49:2819-2823
7. Johnson JA, Bowker SL, Richardson K, Marra CA. Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias. Diabetologia 2011;54:2263-2271
8. Carstensen B, Witte DR, Friis S. Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 2012;55:948-958
9. Colmers IN, Bowker SL, Majumdar SR, Johnson JA. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. CMAJ 2012;184:E675-E683
10. Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H. Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia 2012;55:1953- 1962
11. Lewis JD, Ferrara A, Peng T, et al. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study. Diabetes Care 2011;34:916-922
12. Azoulay L, Yin H, Filion KB, et al. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ 2012;344: e3645
13. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-516
14. Responding to the challenge of diabetes in Canada: first report of the national diabetes surveillance system (NDSS) [Internet]. Ottawa, ON, Public Health Association of Canada, Government of Canada, 2003 [cited 2012 Aug 17]. Available from http:// www.phac-aspc.gc.ca/ccdpc-cpcmc/ndsssnsd/ english/pubs-reports/pdf/WEB-NDSS- English-Report-nocover.pdf. Accessed 17 August 2012
15. Wennberg JE, Staiger DO, Sharp SM, et al. Observational intensity bias associated with illness adjustment: cross sectional analysis of insurance claims. BMJ 2013; 346:f549
16. R Development Core Team. R: A language and environment for statistical computing [Internet]. Vienna, Austria, R Foundation for Statistical Computing, 2008. Available from http://www.R-project.org. Accessed 17 August 2012
17. Renehan AG, Yeh H-C, Johnson JA, Wild SH, Gale EA, Møller H; Diabetes and Cancer Research Consortium. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 2012;55:1619-1632
18. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010;33:1674-1685
19. Logsetty S. Screening for bladder cancer. In The Canadian Guide to Clinical Preventive Health Care [Internet]. Ottawa, ON, Public Health Agency of Canada, 1993. Available from http:// www.phac-aspc.gc.ca/publicat/ clinicclinique/ pdf/s10c68e.pdf. Accessed 17 August 2012
20. Khadra MH, Pickard RS, Charlton M, Powell PH, Neal DE. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. JUrol 2000;163:524-527
21. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66 (Suppl. 1):4-34